Results 11 to 20 of about 212,315 (369)

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Circulation, 2022
Supplemental Digital Content is available in the text. Background: Direct oral anticoagulants (DOACs) are preferred over warfarin for stroke prevention in atrial fibrillation.
Anthony P. Carnicelli, H. Hong, S. Connolly, J. Eikelboom, R. Giugliano, D. Morrow, M. Patel, L. Wallentin, J. Alexander, M. Bahit, A. Benz, E. Bohula, T. Chao, L. Dyal, M. Ezekowitz, K. Fox, B. Gencer, J. Halperin, Z. Hijazi, S. Hohnloser, Kaiyuan Hua, E. Hylek, Eri Toda Kato, J. Kuder, R. Lopes, K. Mahaffey, J. Oldgren, J. Piccini, C. Ruff, J. Steffel, D. Wojdyla, C. Granger   +31 more
semanticscholar   +1 more source

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

New England Journal of Medicine, 2011
BACKGROUND The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment.
S. Pearson, R. Troughton, A. Richards
semanticscholar   +2 more sources

Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial

Blood Advances, 2021
Key Points The primary outcome, stroke, occurred in 6 of 23 patients randomized to apixaban compared with 0 of 25 patients randomized to warfarin. This study with limitations suggests that apixaban is not an equitable substitute for warfarin to prevent ...
S. Woller, S. Stevens, David A Kaplan, Tzu‐Fei Wang, D. Branch, Danielle Groat, E. Wilson, Brent P. Armbruster, V. Aston, J. Lloyd, M. Rondina, C. Elliott   +11 more
semanticscholar   +1 more source

Dabigatran versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2009
BACKGROUND Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor.
S. Connolly, M. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P. Reilly, E. Themeles, Jeanne Varrone, Susan Wang, M. Alings, D. Xavier, Jun Zhu, R. Diaz, B. Lewis, H. Darius, H. Diener, C. Joyner, L. Wallentin   +19 more
semanticscholar   +1 more source

Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.

JAMA cardiology, 2020
Importance Left ventricular (LV) thrombi can arise in patients with ischemic and nonischemic cardiomyopathies. Anticoagulation is thought to reduce the risk of stroke or systemic embolism (SSE), but there are no high-quality data on the effectiveness of ...
A. Robinson, C. Trankle, G. Eubanks, C. Schumann, P. Thompson, Ryan Wallace, S. Gottiparthi, Benjamin K Ruth, C. Kramer, M. Salerno, K. Bilchick, C. Deen, M. Kontos, J. Dent   +13 more
semanticscholar   +1 more source

Edoxaban versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2013
BACKGROUND Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known.
R. Giugliano, C. Ruff, E. Braunwald, S. Murphy, S. Wiviott, J. Halperin, A. Waldo, M. Ezekowitz, J. Weitz, J. Špinar, W. Rużyłło, M. Ruda, Y. Koretsune, Joshua Betcher, M. Shi, L. Grip, Shirali P Patel, Indravadan Patel, J. Hanyok, M. Mercuri, E. Antman   +20 more
semanticscholar   +1 more source

A framework model for a contextualized and integrated warfarin therapy case in a master of pharmacy program [PDF]

, 2019
© Copyright 2019 American Journal of Pharmaceutical Education.Objective. To develop and integrate a case study on warfarin into a clinical pharmacy workshop. Methods. A framework model was designed and used to create a case study on warfarin therapy. The
Birdi, Amandeep, Fergus, Suzanne, Riaz, Farakh   +2 more
core   +1 more source

An albumin-derived peptide scaffold capable of binding and catalysis [PDF]

, 2012
We have identified a 101-amino-acid polypeptide derived from the sequence surrounding the IIA binding site of human albumin. The polypeptide contains residues that make contact with ligands as warfarin in the parent protein, and eight cysteine residues ...
Adriano Savoini, Alessandro Tossi, Daniele Sblattero, Elisa Maurizio, Fabio Benedetti, Federico Berti, Giampaolo Fontanive, Immacolata Luisi, Riccardo Sgarra, Silvia Pavan   +9 more
core   +7 more sources

Warfarin and beetroot [PDF]

Australian Prescriber, 2016
The recent Letter to the Editor about warfarin and beetroot by Louise Vanpraag and the response from Philip Tideman and colleagues1 both miss the point about warfarin and beetroot. It is commonplace for those eating beetroot to have red urine (beeturia) or red faeces, or both, and such symptoms in those taking warfarin can be worrying.
John Raven, Philip A Tideman, Rosy Tirimacco, Andrew St John, Gregory W Roberts   +4 more
openaire   +3 more sources

Standardized warfarin monitoring decreases adverse drug reactions

BMC Family Practice, 2019
Background While warfarin is the most commonly prescribed medication to prevent thromboembolic disorders, the risk of adverse drug reactions (ADR) poses a serious concern.
Lisa B. E. Shields, Paula Fowler, Diane M. Siemens, Douglas J. Lorenz, Kenneth C. Wilson, Steven T. Hester, Joshua T. Honaker   +6 more
doaj   +1 more source